neoSurgical Inc. has announced that the company’s neoClose system for port site closure after Laparoscopic surgery has been used 2,000 times in hospitals across the U.S. Northwestern Memorial-Prentice Hospital in Chicago is the newest addition to neoSurgical’s growing U.S. hospital customer base.

Two recently published clinical studies have shown that trocar site hernia (TSH) is highly prevalent in port site closures post-Lap surgery. TSH can lead to significant morbidity, often requiring surgical intervention, frequently as emergency.

“neoClose offers surgeons a new alternative designed to reduce the risk of post-Lap-surgery herniation at the port site,” said Magdy P. Milad, M.D., the Albert B. Gerbie Professor and Chief of Gynecology and Gynecologic Surgery at Northwestern Memorial Hospital, Chicago, and the Vice-Chair of Education in the Department of Obstetrics and Gynecology at Northwestern Medicine.

Laparoscopic abdominal surgery requires a hole or “port site” in the abdomen. The port site must be closed, of course, after Lap surgery. While Lap surgery itself is minimally invasive, herniation, or protrusion of abdominal tissue through the port site after closure (commonly referred to as trocar site hernia, or TSH, among doctors), can lead to morbidity due to small bowel strangulation, for example, or nerve and vessel entrapment, resulting in infection, bleeding and pain.

The standard for port site closure has been Closed Loop Suture. Now, there’s neoClose. neoClose works by the use of a Vector X closure, approximating the tissue together and tying into place for a secure closure with up to 75 percent less tension compared to standard closed loop suture.